Chris Goodman, MD

Definitive radiotherapy for oropharyngeal cancer (OPC) requires adequate PTV coverage, but the optimal degree of target coverage is unknown. Some protocols require a PTVD95≥95% whereas others require PTVD95≥100% of prescription dose. Prescribing higher PTV do...